Device report from depuy synthes reports an event in japan as follows: it was reported that the initial surgery (l5/s) using screws of expedium was performed on (b)(6) 2016.On (b)(6) 2023, a plif (l2/3/4) using a competitor¿s products was performed.At first, removal of the screws of expedium at l5/s were not planned in the plif.But the surgeon changed the plan and consulted with the sales rep.The sales rep suggested to use the screwdrivers for expedium.The surgeon could remove the screw at l5 but could not remove the screw at s partly because the bone had hardened.During removal of the screw at s, two (2) screwdrivers broke.The screw at s was determined to be remained in the body because it was not planned to be removed originally.The plif was completed successfully with no surgical delay.No further information is available.This report is for one (1) unk - screws: expedium.This is report 2 of 3 for complaint (b)(4).
|
Depuy synthes is submitting this report pursuant to the provisions of 21 cfr, part 803.This report may be based on information which depuy synthes has not been able to investigate or verify prior to the required reporting date.This report does not reflect a conclusion by fda, depuy synthes or its employees that the report constitutes an admission that the device, depuy synthes, or its employees caused or contributed to the potential event described in this report.D1, d2, d3, d4, g4-510k: this report is for an unknown expedium screw/unknown lot.Part and lot number are unknown.Without the specific part number.The udi number and 510-k number is unknown.D9: complainant part is not expected to be returned for manufacturer review/investigation.E3: reporter is a j&j sales representative.H3, h4, h6: without a lot number the device history records review could not be completed.The investigation could not be completed, no conclusion could be drawn, as no product was received.Based on the information available, it has been determined that no corrective and/or preventative action is proposed.This complaint will be accounted for and monitored via post market surveillance activities.If additional information is made available, the investigation will be updated as applicable.Device was used for treatment, not diagnosis.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
|